Eutropics Pharmaceuticals To Present Data On Personalized Diagnostic For Leukemia Patient Management At American Society of Hematology 2013

Eutropics Pharmaceuticals will present data from two recent clinical investigations at the 55th Annual American Society for Hematology Meeting to be held in New Orleans, LA December 7-11, 2013. These studies demonstrate the medical utility of Eutropics’ proprietary biomarker platform, PraediCare-Dx (aka BH3 profiling), in predicting patient response to cancer treatment.

Help employers find you! Check out all the jobs and post your resume.